Qilu Pharma got CEP for Ondansetron HCl

Recently, we received CEP for Ondansetron HCl from EDQM. It is the second CEP granted to Qilu Pharma this year while the other is for Terbinafine HCl.

EDQM issued the certificate based on the review of our DMF without site inspection. It demonstrate that Qilu has a very strong capability on regulatory affairs and quality management.